A Study to Detect and Candida auris

Overview

About this study

The purpose of this study is to develop a test that can be used routinely to detect and identify Candida auris from surveillance skin swabs.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

Patients admitted to Saint Mary’s Hospital or Methodist Hospital who have one of the following

  • Reported travel or residence outside of the United States in the last 6 months;
  • Report an address in a State/zip code where C. auris transmission has been reported;
  • Report an address in a country where C. auris transmission has been reported.

Exclusion Criteria:

  • Patient is in Observation on any unit.
  • Patient has tested negative in the past six months.
  • Patient is no longer hospitalized (has been discharged).
  • Patient refuses verbal assent.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nancy Wengenack, Ph.D.

Open for enrollment

Contact information:

Mohamed Ibrahim

(507)284-4115

Ibrahim.Mohamed@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available